CVS - CVS Health Corp Stock Analysis

CVS Health Corp (CVS) is a publicly traded company listed on the NYSE. It operates in the Healthcare Plans industry, part of the broader Healthcare sector. The company has a market capitalization of 98.77B, generates annual revenue of 393.94B, and reports net income of 469.00M. As of the latest data, the stock is trading at 77.81 USD.

From a valuation and risk perspective, the stock presents the following profile: The stock is trading at a high valuation compared to the market average, suggesting investor optimism or growth expectations. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company uses a significant amount of debt to finance its operations, which can boost returns but adds financial risk. The stock offers a moderate dividend yield (3.42%), which may appeal to income-focused investors. This stock tends to be less volatile than the overall market, often preferred by conservative investors.

Analyst recommendation stands at Buy (4.0), indicating current market sentiment. Institutional ownership is reported at 88.79%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 44.01%, trading within a 52-week range of 43.56 - 85.15.

CVS - CVS Health Corp

77.81
Analyst Consensus
Buy 4.0
CVS – Analyst Rating Summary
Analyst Pie Chart
  • Strong Buy: 7
  • Buy: 20
  • Hold: 7
  • Sell: 0
  • Strong Sell: 0
  • Total Analysts:  34

Last update: 2025-11-16 04:56:08
Index: S&P 500 P/E: 203.32 EPS (ttm): 0.38 Insider Own: 0.12% Shs Outstand: 1.27B Perf Week: -1.49%
Market Cap: 98.77B Forward P/E: 10.86 EPS next Y: 7.17 Insider Trans: -0.38% Shs Float: 1.27B Perf Month: -4.38%
Income(ttm): 469.00M PEG: 14.03 EPS next Q: 0.96 Inst Own: 88.79% Short Float: 1.49% Perf Quarter: 10.89%
Revenue(ttm): 393.94B P/S: 0.25 EPS this Y: 21.48% Inst Trans: -0.02% Short Ratio: 2.56 Perf Half Y: 24.44%
Book/sh: 57.42 P/B: 1.36 EPS next Y: 8.84% ROA: 0.18% Short Interest: 18.90M Perf Year: 44.01%
Cash/sh: 8.89 P/C: 8.75 EPS next 5Y: 14.49% ROE: 0.63% 52W Range: 43.56 - 85.15 Perf YTD: 73.33%
Dividend Est.: 2.66 (3.42%) P/FCF: 15.70 EPS past 3/5Y: -14.99% -6.37% ROIC: 0.32% 52W High: 85.15 -8.62% Beta: 0.48
Dividend TTM: 2.66 (3.42%) Quick Ratio: 0.63 Sales past 3/5Y: 8.48% 7.75% Gross Margin: 13.85% 52W Low: 43.56 78.63% Perf 5Y: 15.22%
Dividend Ex-Date: Oct 23, 2025 Current Ratio: 0.83 EPS Y/Y TTM: -90.11% Oper. Margin: 3.19% RSI (14): 45.94 Volatility: 2.79% 2.39%
Employees: 300000 Debt/Eq: 1.12 Sales Y/Y TTM: 6.71% Profit Margin: 0.12% Recom: 1.50 Target Price: 91.67
Option/Short: Yes / Yes LT Debt/Eq: 1.02 EPS Q/Q: -4633.14% Payout: 72.76% Rel Volume: 0.70 Prev Close: 79.24
Sales Surprise: 4.11% EPS Surprise: 17.21% Sales Q/Q: 7.83% Earnings: Oct 29 BMO Avg Volume: 7.37M Price: 77.81
SMA20: -2.62% SMA50: 0.18% SMA200: 13.73% Undervalued: 17.81%
Volume: 5,169,744 Change: -1.80%
Graham's revised valuation formula
Discounted cash flow (DCF) model
Margin of safety

About CVS Health Corp

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.

Copyright © 2024 - 2025 www.stocks-expert.com All Rights Reserved.